Identification of glycoprotein markers for pancreatic cancer CD24 +CD44 + stem-like cells using nano-LC-MS/MS and tissue microarray

Journal of Proteome Research

Volumn 11, Issue 4, 2012, Pages 2272-2281

  Zhu, Jianhui ^a   He, Jintang ^a   Liu, Yashu ^a   Simeone, Diane M ^a   Lubman, David M ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

CD24; glycoprotein; LC MS MS; lectin affinity chromatography; pancreatic cancer; stem like cells; tissue microarray

Indexed keywords

BETA1 INTEGRIN; CD24 ANTIGEN; CYTOKERATIN 8; FUCOSE; GALACTOSE; GLYCOPROTEIN; HERMES ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; MICROSOMAL AMINOPEPTIDASE; ULEX EUROPAEUS AGGLUTININ;

AFFINITY CHROMATOGRAPHY; APICAL MEMBRANE; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CANCER STAGING; CANCER STEM CELL; CELL ISOLATION; CELL SUBPOPULATION; CONTROLLED STUDY; DOLICHOS; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PANCREAS ADENOCARCINOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MICROARRAY; TISSUE MICROARRAY; TUMOR GROWTH; UPREGULATION;

ADENOCARCINOMA; ANTIGENS, CD24; ANTIGENS, CD44; BLOTTING, WESTERN; CELL LINE, TUMOR; CHROMATOGRAPHY, AFFINITY; HUMANS; IMMUNOHISTOCHEMISTRY; NANOTECHNOLOGY; NEOPLASTIC STEM CELLS; PANCREAS; PANCREATIC NEOPLASMS; TANDEM MASS SPECTROMETRY; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84859585375     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr201059g     Document Type: Article

References (55)

1. Jemal, A.; Siegel, R.; Ward, E.; Murray, T.; Xu, J.; Smigal, C.; Thun, M. J. Cancer statistics, 2006 CA Cancer J. Clin. 2006, 56 (2) 106-130
2. Philip, P. A.; Mooney, M.; Jaffe, D.; Eckhardt, G.; Moore, M.; Meropol, N.; Emens, L.; OReilly, E.; Korc, M.; Ellis, L.; Benedetti, J.; Rothenberg, M.; Willett, C.; Tempero, M.; Lowy, A.; Abbruzzese, J.; Simeone, D.; Hingorani, S.; Berlin, J.; Tepper, J. Consensus report of the national cancer institute clinical trials planning meeting on pancreas cancer treatment J. Clin. Oncol. 2009, 27 (33) 5660-5669
3. Lonardo, E.; Hermann, P. C.; Heeschen, C. Pancreatic cancer stem cells-update and future perspectives Mol. Oncol. 2010, 4 (5) 431-442
4. Bonnet, D.; Dick, J. E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell Nat. Med. 1997, 3 (7) 730-737
5. Al-Hajj, M.; Wicha, M. S.; Benito-Hernandez, A.; Morrison, S. J.; Clarke, M. F. Prospective identification of tumorigenic breast cancer cells Proc. Natl. Acad. Sci. U.S.A. 2003, 100 (7) 3983-3988
6. Galli, R.; Binda, E.; Orfanelli, U.; Cipelletti, B.; Gritti, A.; De Vitis, S.; Fiocco, R.; Foroni, C.; Dimeco, F.; Vescovi, A. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma Cancer Res. 2004, 64 (19) 7011-7021
7. Singh, S. K.; Hawkins, C.; Clarke, I. D.; Squire, J. A.; Bayani, J.; Hide, T.; Henkelman, R. M.; Cusimano, M. D.; Dirks, P. B. Identification of human brain tumour initiating cells Nature 2004, 432 (7015) 396-401
8. Ricci-Vitiani, L.; Lombardi, D. G.; Pilozzi, E.; Biffoni, M.; Todaro, M.; Peschle, C.; De Maria, R. Identification and expansion of human colon-cancer-initiating cells Nature 2007, 445 (7123) 111-115
9. Li, C.; Heidt, D. G.; Dalerba, P.; Burant, C. F.; Zhang, L.; Adsay, V.; Wicha, M.; Clarke, M. F.; Simeone, D. M. Identification of pancreatic cancer stem cells Cancer Res. 2007, 67 (3) 1030-1037
10. Hermann, P. C.; Huber, S. L.; Herrler, T.; Aicher, A.; Ellwart, J. W.; Guba, M.; Bruns, C. J.; Heeschen, C. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer Cell Stem Cell 2007, 1 (3) 313-323
11. Visvader, J. E.; Lindeman, G. J. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions Nat. Rev. Cancer 2008, 8 (10) 755-768
12. Durand, G.; Seta, N. Protein glycosylation and diseases: blood and urinary oligosaccharides as markers for diagnosis and therapeutic monitoring Clin. Chem. 2000, 46 (6 Pt 1) 795-805
13. Block, T. M.; Comunale, M. A.; Lowman, M.; Steel, L. F.; Romano, P. R.; Fimmel, C.; Tennant, B. C.; London, W. T.; Evans, A. A.; Blumberg, B. S.; Dwek, R. A.; Mattu, T. S.; Mehta, A. S. Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans Proc. Natl. Acad. Sci. U.S.A. 2005, 102 (3) 779-784
14. Dube, D. H.; Bertozzi, C. R. Glycans in cancer and inflammation - potential for therapeutics and diagnostics Nat. Rev. Drug Discovery 2005, 4 (6) 477-488
15. He, J.; Liu, Y.; Zhu, T. S.; Xie, X.; Costello, M. A.; Talsma, C. E.; Flack, C. G.; Crowley, J. G.; Dimeco, F.; Vescovi, A. L.; Fan, X.; Lubman, D. M. Glycoproteomic analysis of glioblastoma stem cell differentiation J. Proteome Res. 2011, 10 (1) 330-338
16. Pilobello, K. T.; Mahal, L. K. Lectin microarrays for glycoprotein analysis Methods Mol. Biol. 2007, 385, 193-203
17. Qiu, R.; Regnier, F. E. Use of multidimensional lectin affinity chromatography in differential glycoproteomics Anal. Chem. 2005, 77 (9) 2802-2809
18. Hirabayashi, J. Lectin-based structural glycomics: glycoproteomics and glycan profiling Glycoconj J. 2004, 21 (1-2) 35-40
19. Kuno, A.; Uchiyama, N.; Koseki-Kuno, S.; Ebe, Y.; Takashima, S.; Yamada, M.; Hirabayashi, J. Evanescent-field fluorescence-assisted lectin microarray: a new strategy for glycan profiling Nat. Methods 2005, 2 (11) 851-856
20. Xiong, L.; Andrews, D.; Regnier, F. Comparative proteomics of glycoproteins based on lectin selection and isotope coding J. Proteome Res. 2003, 2 (6) 618-625
21. North, S. J.; Hitchen, P. G.; Haslam, S. M.; Dell, A. Mass spectrometry in the analysis of N-linked and O-linked glycans Curr. Opin. Struct. Biol. 2009, 19 (5) 498-506
22. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 1976, 72, 248-254
23. Griffin, N. M.; Yu, J.; Long, F.; Oh, P.; Shore, S.; Li, Y.; Koziol, J. A.; Schnitzer, J. E. Label-free, normalized quantification of complex mass spectrometry data for proteomic analysis Nat. Biotechnol. 2010, 28 (1) 83-89
24. Madden, M. E.; Sarras, M. P., Jr. Morphological and biochemical characterization of a human pancreatic ductal cell line (PANC-1) Pancreas 1988, 3 (5) 512-528
25. Friederichs, J.; Zeller, Y.; Hafezi-Moghadam, A.; Grone, H. J.; Ley, K.; Altevogt, P. The CD24/P-selectin binding pathway initiates lung arrest of human A125 adenocarcinoma cells Cancer Res. 2000, 60 (23) 6714-6722
26. Baumann, P.; Cremers, N.; Kroese, F.; Orend, G.; Chiquet-Ehrismann, R.; Uede, T.; Yagita, H.; Sleeman, J. P. CD24 expression causes the acquisition of multiple cellular properties associated with tumor growth and metastasis Cancer Res. 2005, 65 (23) 10783-10793
27. Aigner, S.; Ramos, C. L.; Hafezi-Moghadam, A.; Lawrence, M. B.; Friederichs, J.; Altevogt, P.; Ley, K. CD24 mediates rolling of breast carcinoma cells on P-selectin FASEB J. 1998, 12 (12) 1241-1251
28. Senner, V.; Sturm, A.; Baur, I.; Schrell, U. H.; Distel, L.; Paulus, W. CD24 promotes invasion of glioma cells in vivo J. Neuropathol. Exp. Neurol. 1999, 58 (8) 795-802
29. Yamashita, K.; Kochibe, N.; Ohkura, T.; Ueda, I.; Kobata, A. Fractionation of L-fucose-containing oligosaccharides on immobilized Aleuria aurantia lectin J. Biol. Chem. 1985, 260 (8) 4688-4693
30. Debray, H.; Montreuil, J. Aleuria aurantia agglutinin. A new isolation procedure and further study of its specificity towards various glycopeptides and oligosaccharides Carbohydr. Res. 1989, 185 (1) 15-26
31. An, H. J.; Kronewitter, S. R.; de Leoz, M. L.; Lebrilla, C. B. Glycomics and disease markers Curr. Opin. Chem. Biol. 2009, 13 (5-6) 601-607
32. Okuyama, N.; Ide, Y.; Nakano, M.; Nakagawa, T.; Yamanaka, K.; Moriwaki, K.; Murata, K.; Ohigashi, H.; Yokoyama, S.; Eguchi, H.; Ishikawa, O.; Ito, T.; Kato, M.; Kasahara, A.; Kawano, S.; Gu, J.; Taniguchi, N.; Miyoshi, E. Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation Int. J. Cancer 2006, 118 (11) 2803-2808
33. Wang, Y.; Ao, X.; Vuong, H.; Konanur, M.; Miller, F. R.; Goodison, S.; Lubman, D. M. Membrane glycoproteins associated with breast tumor cell progression identified by a lectin affinity approach J. Proteome Res. 2008, 7 (10) 4313-4325
34. Sardiu, M. E.; Washburn, M. P. Enriching quantitative proteomics with SI(N) Nat. Biotechnol. 2010, 28 (1) 40-42
35. Franke, W. W.; Schiller, D. L.; Moll, R.; Winter, S.; Schmid, E.; Engelbrecht, I.; Denk, H.; Krepler, R.; Platzer, B. Diversity of cytokeratins. Differentiation specific expression of cytokeratin polypeptides in epithelial cells and tissues J. Mol. Biol. 1981, 153 (4) 933-959
36. Gires, O.; Mack, B.; Rauch, J.; Matthias, C. CK8 correlates with malignancy in leukoplakia and carcinomas of the head and neck Biochem. Biophys. Res. Commun. 2006, 343 (1) 252-259
37. Fillies, T.; Werkmeister, R.; Packeisen, J.; Brandt, B.; Morin, P.; Weingart, D.; Joos, U.; Buerger, H. Cytokeratin 8/18 expression indicates a poor prognosis in squamous cell carcinomas of the oral cavity BMC Cancer 2006, 6, 10
38. Makino, T.; Yamasaki, M.; Takeno, A.; Shirakawa, M.; Miyata, H.; Takiguchi, S.; Nakajima, K.; Fujiwara, Y.; Nishida, T.; Matsuura, N.; Mori, M.; Doki, Y. Cytokeratins 18 and 8 are poor prognostic markers in patients with squamous cell carcinoma of the oesophagus Br. J. Cancer 2009, 101 (8) 1298-1306
39. White, D. E.; Kurpios, N. A.; Zuo, D.; Hassell, J. A.; Blaess, S.; Mueller, U.; Muller, W. J. Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction Cancer Cell 2004, 6 (2) 159-170
40. Grzesiak, J. J.; Cao, H. S.; Burton, D. W.; Kaushal, S.; Vargas, F.; Clopton, P.; Snyder, C. S.; Deftos, L. J.; Hoffman, R. M.; Bouvet, M. Knockdown of the beta(1) integrin subunit reduces primary tumor growth and inhibits pancreatic cancer metastasis Int. J. Cancer 2011, 129 (12) 2905-2915
41. Lawson, C.; Wolf, S. ICAM-1 signaling in endothelial cells Pharmacol. Rep. 2009, 61 (1) 22-32
42. Shimoyama, S.; Gansauge, F.; Gansauge, S.; Widmaier, U.; Oohara, T.; Beger, H. G. Overexpression of intercellular adhesion molecule-1 (ICAM-1) in pancreatic adenocarcinoma in comparison with normal pancreas Pancreas 1997, 14 (2) 181-186
43. Roland, C. L.; Harken, A. H.; Sarr, M. G.; Barnett, C. C., Jr. ICAM-1 expression determines malignant potential of cancer Surgery 2007, 141 (6) 705-707
44. Schroder, C.; Witzel, I.; Muller, V.; Krenkel, S.; Wirtz, R. M.; Janicke, F.; Schumacher, U.; Milde-Langosch, K. Prognostic value of intercellular adhesion molecule (ICAM)-1 expression in breast cancer J. Cancer Res. Clin. Oncol. 2011, 137 (8) 1193-1201
45. Kelleher, D. J.; Kreibich, G.; Gilmore, R. Oligosaccharyltransferase activity is associated with a protein complex composed of ribophorins I and II and a 48 kd protein Cell 1992, 69 (1) 55-65
46. Honma, K.; Iwao-Koizumi, K.; Takeshita, F.; Yamamoto, Y.; Yoshida, T.; Nishio, K.; Nagahara, S.; Kato, K.; Ochiya, T. RPN2 gene confers docetaxel resistance in breast cancer Nat. Med. 2008, 14 (9) 939-948
47. Razak, K.; Newland, A. C. The significance of aminopeptidases and haematopoietic cell differentiation Blood Rev. 1992, 6 (4) 243-250
48. Mina-Osorio, P. The moonlighting enzyme CD13: old and new functions to target Trends Mol. Med. 2008, 14 (8) 361-371
49. Wulfaenger, J.; Niedling, S.; Riemann, D.; Seliger, B. Aminopeptidase N (APN)/CD13-dependent CXCR4 downregulation is associated with diminished cell migration, proliferation and invasion Mol. Membr. Biol. 2008, 25 (1) 72-82
50. Di Matteo, P.; Arrigoni, G. L.; Alberici, L.; Corti, A.; Gallo-Stampino, C.; Traversari, C.; Doglioni, C.; Rizzardi, G. P. Enhanced expression of CD13 in vessels of inflammatory and neoplastic tissues J. Histochem. Cytochem. 2011, 59 (1) 47-59
51. Ikenaga, N.; Ohuchida, K.; Mizumoto, K.; Yu, J.; Kayashima, T.; Hayashi, A.; Nakata, K.; Tanaka, M. Characterization of CD24 expression in intraductal papillary mucinous neoplasms and ductal carcinoma of the pancreas Hum. Pathol. 2010, 41 (10) 1466-1474
52. Jacob, J.; Bellach, J.; Grutzmann, R.; Alldinger, I.; Pilarsky, C.; Dietel, M.; Kristiansen, G. Expression of CD24 in adenocarcinomas of the pancreas correlates with higher tumor grades Pancreatology 2004, 4 (5) 454-460
53. Pasqualini, R.; Koivunen, E.; Kain, R.; Lahdenranta, J.; Sakamoto, M.; Stryhn, A.; Ashmun, R. A.; Shapiro, L. H.; Arap, W.; Ruoslahti, E. Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis Cancer Res. 2000, 60 (3) 722-727
54. Fukasawa, K.; Fujii, H.; Saitoh, Y.; Koizumi, K.; Aozuka, Y.; Sekine, K.; Yamada, M.; Saiki, I.; Nishikawa, K. Aminopeptidase N (APN/CD13) is selectively expressed in vascular endothelial cells and plays multiple roles in angiogenesis Cancer Lett. 2006, 243 (1) 135-143
55. Bhagwat, S. V.; Lahdenranta, J.; Giordano, R.; Arap, W.; Pasqualini, R.; Shapiro, L. H. CD13/APN is activated by angiogenic signals and is essential for capillary tube formation Blood 2001, 97 (3) 652-659